This led to the assumption that the primary receptors mediating weight loss for this target class were AMYRs, yet, dual agonists are reported to have higher efficacy than AMYR selective agonists 2,10,11,12
Any buildup is just going to prevent the peptide from penetrating into the areas it's actually needed
Many patients report that after about 4 weeks of weekly injections, they observe improvements such as more steady energy levels and easier weight loss progress
Lean mass preservation remains relatively good because AOD 9604 selectively targets adipose tissue while tirzepatide maintains favorable lean-to-fat loss ratios
Both methods work, but injections provide stronger benefits, while topical use only targets skin and hair
The ideal conditions revolve around two key factors: temperature and humidity levels